0000730464false00007304642026-11-192026-11-19

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

​

FORM 8-K/A

Amendment No. 2

​

CURRENT REPORT

​

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

​

Date of Report (Date of earliest event reported): November 11, 2026

​

Covista Inc.

(Exact name of registrant as specified in its charter)

 

Delaware

001-13988

36-3150143

(State or other jurisdiction of incorporation)

(Commission File Number)

(IRS Employer Identification No.)

 

 

 

233 South Wacker Drive Suite 800,

Chicago, IL

 

60606

(Address of principal executive offices)

 

(Zip Code)

​

(312) (651-1400)

(Registrant’s telephone number, including area code)

​

N/A

(Former name or former address, if changed since last report)

​

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

​

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

​

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

​

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

​

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

​

Securities registered pursuant to Section 12(b) of the Act:

​

​

​

Title of each class

  ​ ​ ​

Trading Symbol

  ​ ​ ​

Name of each exchange on
which registered

Common Stock $0.01 Par Value

​

CVSA

​

New York Stock Exchange

Common Stock $0.01 Par Value

​

CVSA

​

NYSE Texas

​

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

​

Emerging growth company ☐

​

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Graphic

​

​

EXPLANATORY NOTE

 

As previously disclosed, on October 1, 2026, the Board of Directors (the “Board”) of Covista Inc. (“Covista” or the “Company”) approved the Covista Inc. 2026 Equity Incentive Plan (the “Plan”), which was then submitted to and approved by the Company’s shareholders at the Company’s 2026 Annual Meeting of Shareholders held on November 11, 2026. That approval was reported in the Company’s Current Report on Form 8-K/A (the “Prior Form 8-K”) filed with the Securities and Exchange Commission (the “SEC”) on November 13, 2026. This Current Report on Form 8-K/A is being filed to update the Prior Form 8-K as well as the Company’s Registration Statement on Form S-8 relating to the Plan, which was filed with the SEC on November 4, 2026, by filing an updated opinion of counsel required by Item 601(b)(5) of Regulation S-K to remove the assumption of the receipt of shareholder approval of the Plan now that shareholder approval has been obtained.

​

Item 8.01Other Events

​

In connection with the potential issuance and sale of shares of the Company’s common stock pursuant to the Plan, as referenced in the Explanatory Note, the Company is filing as Exhibit 5.1 to this Current Report on Form 8-K/A an updated legal opinion of Nelson Mullins Riley & Scarborough LLP relating to the legality of the shares of common stock that may be issued by the Company pursuant to the Plan.

​

​

Item 9.01         Financial Statements and Exhibits

​

See Exhibit Index below

​

​

5.1

  ​ ​ ​

Opinion of Nelson Mullins Riley & Scarborough LLP

23.1

​

Consent of Nelson Mullins Riley & Scarborough LLP (included in Exhibit 5.1)

104

​

Cover Page Interactive Data File (formatted in Inline XBRL and included as Exhibit 101)

​

​

​

​

​

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

​

Covista Inc.

​

​

​

By:

/s/ Douglas G. Beck

​

​

Douglas G. Beck

​

​

Senior Vice President, General Counsel and Corporate Secretary and Institutional Support Services

​

Date: November 19, 2026